Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Illidge

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology GroupTim Illidge, Lena Specht, Joachim Yahalom, et al.
Blood|April 11, 2020
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemicJoachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, et al.
British Journal of Haematology|September 22, 2018
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United KingdomPaul J Bröckelmann, Suzanne McMullen, J Ben Wilson, et al.
British Journal of Haematology|June 25, 2020
The investigation and management of follicular lymphomaChristopher McNamara, Silvia Montoto, Toby A Eyre, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshopPier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2013
Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)Lena Specht, Joachim Yahalom, Tim Illidge, et al.
British Journal of Haematology|October 13, 2012
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemiaDavid Oscier, Claire Dearden, Efrem Eren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin LymphomaDavid J Cutter, Johanna Ramroth, Patricia Diez, et al.
Blood Advances|January 8, 2025
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international studyElizabeth H Phillips, Nicholas Counsell, Tim Illidge, et al.
The Lancet. Oncology|February 4, 2021
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trialPeter Hoskin, Biliana Popova, Oliver Schofield, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology GroupTim Illidge, Lena Specht, Joachim Yahalom, et al.
Blood|April 11, 2020
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemicJoachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, et al.
British Journal of Haematology|September 22, 2018
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United KingdomPaul J Bröckelmann, Suzanne McMullen, J Ben Wilson, et al.
British Journal of Haematology|June 25, 2020
The investigation and management of follicular lymphomaChristopher McNamara, Silvia Montoto, Toby A Eyre, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshopPier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2013
Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)Lena Specht, Joachim Yahalom, Tim Illidge, et al.
British Journal of Haematology|October 13, 2012
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemiaDavid Oscier, Claire Dearden, Efrem Eren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2021
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin LymphomaDavid J Cutter, Johanna Ramroth, Patricia Diez, et al.
Blood Advances|January 8, 2025
Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international studyElizabeth H Phillips, Nicholas Counsell, Tim Illidge, et al.
The Lancet. Oncology|February 4, 2021
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trialPeter Hoskin, Biliana Popova, Oliver Schofield, et al.
Pageof 7